Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT04364269Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
NCT05514951Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT01131624Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT04938635Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
NCT00810004Maintenance Treatment of Iron Deficiency in IBD Patients
NCT04806048Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT01324752A Drug-Drug Interaction Study of Losartan and PA21
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
NCT05136664Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
NCT01100879Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
NCT05766839Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT02557477Omega 3/6 Fatty Acids for Reading in Children
NCT03769441Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT01913808Comparing Intravenous and Oral Iron in Postoperative Anemia
NCT01057004EVIdence Based TreAtment - Heart Failure (EVITA-HF)
NCT05415969CKD-aP Among Adults on Dialysis in Switzerland
NCT03644264PA21 Safety and Efficacy in Adult Chinese Subjects
NCT00520780Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT05034250Iron Status in Female Infertility and Recurrent Miscarriage
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
NCT01513369Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
NCT04903717Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT05897684Avacostar - (PASS)
NCT02243735Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
NCT01345968Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
NCT05077436Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects
NCT04249648Hyperkalaemia and Its Impact on Therapy with RAASi
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT06434025IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
NCT03759964Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
NCT03071263Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
NCT01324128A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
NCT01810939A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
NCT01110356Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
NCT01288651Iron Deficiency In Pulmonary Hypertension
NCT03010072The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
NCT02147795The German Patient Blood Management Network
NCT00868439Evaluation of Patiromer in Heart Failure Patients
NCT03214627Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
NCT05786469Patiromer Trial in CKD Stage IIIB to V
NCT01394562Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT00706667Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
NCT05389826mHealth for Phosphorus Management in CKD.
NCT03087058Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
NCT01219309Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT02033317An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis